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Available online 2 March 2016Purpose: Pathologic fractures in patients with bone metastases are a common problem in clinical orthopaedic
routine. On one hand recognition of metastatic lesions, which are at a high risk of fracture, is essential for timely
prophylactic ﬁxation, while on the other hand patients with a low risk of pathologic fractures should be spared
from overtreatment.
The purpose of this review is to identify all methods for fracture risk evaluation in patients with femoral
metastases in the literature and to evaluate their predictive values in clinical applications.
Methods: A MEDLINE database literature research was conducted in order to identify clinical scoring systems,
conclusions from prospective and retrospective radiologic and/or clinical studies, as well as data from biome-
chanical experiments, numerical computational methods, and computer simulations.
Results: The search identiﬁed 441 articles of which 18 articles met the inclusion criteria; 4 more articles were
identiﬁed from citations of the primarily found studies. In principle there are two distinctmethodologies, namely
fracture risk prediction factors based on clinical and radiological data such as themost deployed theMirels' score
and fracture risk prediction based on engineering methods. Fracture risk prediction using Mirels' score, based on
pure clinical data, shows a negative predictive value between 86 and 100%, but moderate to poor results in
predicting non-impending fractures with a positive predictive value between 23 and 70%. Engineering methods
provide a high accuracy (correlation coefﬁcient between ex vivo and results from numerical calculations:
0.68 b r2 b 0.96) in biomechanical lab experiments, but have not been applied to clinical routine yet.
Conclusion: This review clearly points out a lack of adequate clinical methods for fracture risk prediction in
patients with femoralmetastases. Today's golden standard, theMirels' score leads to an overtreatment.Whereas,
engineering methods showed high potential but require a clinical validation. In future deﬁnition of patient-
speciﬁc, quantitative risk factor based modelling methods could serve as useful decision support for individual-
ized treatment strategies in patients with a metastatic lesion.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Femur
Metastatic lesion
Risk prediction
Mirels' score1. Introduction
Pathologic fractures in patients with metastatic cancer of the breast,
prostate, lung, multiple myeloma, bladder, thyroid, kidney and other
primary carcinomas with skeletal involvement are a common problem
in clinical orthopaedic routine (Fig. 1) (Cheal et al., 1993; Dijstra et al.,
1994; Fidler, 1981; Menck et al., 1988). In a study with nearly 700rthopaedic Surgery, Medical
enca),
ayr@meduniwien.ac.at
indhager@meduniwien.ac.at
. This is an open access article underpatients with breast cancer, almost one third (29%) of patients with
femoral metastases experienced a pathologic fracture (Oda and
Schurman, 1983). Metastatic lesions can be lytic, blastic or of a mixed
type, whereas the majority of all metastatic lesions are lytic and these
lesions have the highest impact on bone strength, which causes patho-
logic fractures. Pathologic fractures of the femur mostly occur during
everyday activities, such as starting to walk, standing, raising from a
chair or bed or stair climbing. Pathologic fractures often require surgical
interventions due to poor healing of the affected bone (Cheal et al., 1993;
Mirels, 1989) and include need of ﬁxation devices and endoprostheses
(Dijstra et al., 1994; Keyak et al., 2007; Palumbo et al., 2014) that are
often augmented with polymethyl methacrylate (Dijstra et al., 1994;
Palumbo et al., 2014; Keene et al., 1986). Prophylactic ﬁxation is general-
ly preferable to the trauma of fracture and its subsequent treatmentthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Conventional radiograph of the left proximal femur of a 73 yr old man diagnosed
with renal cell cancer. Image demonstrates a large lytic lesion involving the femoral
neck and the intertrochanteric regions.
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prophylactic surgery can also play a role in pain reduction, functional im-
provement and an increased quality of life (Dijkstra et al., 1997;Malawer
and Sugarbaker, 2001),while surgery of an established fracture increases
the perioperative morbidity in patients with often non ideal to poor
general condition. While patients with a limited life expectancy and
with impending pathologic fractures can beneﬁt from a surgical inter-
vention, others can be spared from unnecessary procedures if fracture
risk of identiﬁed lesions could be clearly deﬁned.
Current guidelines for the prediction of fracture risk in patients with
bone metastases are based on retrospective studies with small sample
size designed to identify radiographic and clinical factors that are
unique to examined patients who sustained a fracture. Experts seem
to agree that there are no proven and established clinical or radiological
guidelines for fracture risk prediction in metastatic bones (Keyak et al.,
2007; Keene et al., 1986; Hipp et al., 1995; Michaeli et al., 1999; Hong
et al., 2004; Van der Linden et al., 2004; Snyder et al., 2006; Spruijt
et al., 2006; Lee, 2007; Tanck et al., 2009; Derikx et al., 2012).
The aim of this article is to review and evaluate existing clinical and
radiologic risk factors as well as prediction methods for pathologic
fractures in patients with femoral metastases from the literature.2. Methods
A MEDLINE (Medical Literature Analysis and Retrieval System
Online) database literature research via PubMed and also a research
using Google Scholar were conducted for all articles published prior
January 12th, 2016. Keywords for the MEDLINE search included
‘(pathologic OR pathological) AND (fracture OR fractures) AND (bone
OR hip OR femur OR femoral OR subtrochanteric) AND (lesion OR
lesions OR metastases OR metastasis OR metastatic OR defect) AND
(risk OR size OR predict OR predicts OR predicting OR prediction OR
parameter OR parameters)’ in the ﬁeld Title or Abstract. Our keywords
were chosen based on a careful evaluation of abstracts of studies,
authors were familiar with.The initial search suggested 441 articles. The abstracts of these arti-
cles were reviewed by two independent reviewers, and 27 were identi-
ﬁed as relevant articles, published between 1986 (Harrington, 1986)
and 2015. After full review of the articles, as well as additional citations
from these articles, 18 original articles met our ﬁnal inclusion criteria:
full text was available, studies with prospective and retrospective clini-
cal and/or radiological data, studies on engineeringmethods in fracture
risk assessment, biomechanical studies conducted on human, animal or
artiﬁcial bone (Cheal et al., 1993;Mirels, 1989; Keyak et al., 2007; Keene
et al., 1986; Dijkstra et al., 1997; Michaeli et al., 1999; Hong et al., 2004;
Van der Linden et al., 2004; Spruijt et al., 2006; Lee, 2007; Tanck et al.,
2009; van der Linden et al., 2003; Keyak et al., 2005; Alexander Iii
et al., 2013; Sivasundaram et al., 2013; Amanatullah et al., 2014;
Anez-Bustillos et al., 2014; Yosibash et al.). Articles were excluded
from the review as per the following exclusion criteria: unrelated
articles, review articles, case studies, and non-English articles. Four
additional articles (Fidler, 1981; Menck et al., 1988; Derikx et al.,
2012; Snyder et al., 2004) either familiar to the authors from past sur-
veys or derived from the citations of the included articles,were included
in the review (Fig. 2). Seventeen of these 22 articles were published in
either the United States (10) or the Netherlands (7). One article was
published by authors from each of the following countries: Republic of
South Africa, Denmark, Republic of Singapore and Israel.
The ﬁnally selected articles were divided into four categories: radio-
logic and clinical reviews, clinical scoring systems, biomechanical
studies, and ﬁnite element analyses.
3. Results
3.1. Radiological and clinical reviews
Fractures in femora occur predominantly in the diaphysis and the
subtrochanteric region followed by the neck and trochanteric regions
(Menck et al., 1988). Lesions vary greatly in size and shape. Most
authors describe the length and width of the lesion as well as the
percentage of axial cortical involvement of the lesion (Table 1).
The oldest study found on this topic included 66 patients with 100
metastases in long bones with 40 fractures (Fidler, 1981). Based on
plain radiographs the author estimated the percentage of metastatic
circumferential involvement dividing them roughly into four categories
of cortex involved: b25%, 20–50%, 50–75% and N75%. It was concluded,
upon theﬁndingof 39 fractures to have a cortical involvement in the lat-
ter groups that metastatic long bones involving 50–75% and especially
over 75% of the cortex are likely to fracture and should be considered
for prophylactic ﬁxation (Table 1) (Fidler, 1981).
Keene at al. evaluated radiographic and clinical documentation of
203 patients and a total of 220 measurable metastatic lesions on the
proximal femur and femoral shaft in patientswith breast cancer. Twelve
of thesemetastases resulted in a pathological fracture. The authorswere
unable to identify either a speciﬁc percent involvement of the bone or a
critical diameter for metastases that fractured. Despite the average
involvement of bone in fractured femora was higher, the range of
percent involvement was similar to the non-fractured group and it
was concluded that radiographic measurements were of little, if any,
predictive value. A further analysis of other variables, such as age height
and weight did not show a signiﬁcant difference between patients who
suffered a fracture and the ones who did not (Keene et al., 1986).
In 69 pathologic femoral fractures Menck at el. described the geom-
etry of the bone and the metastatic lesion and found the following
metastasis sizes to be critical: axial expansion of cortical destruction
zone in the neck region ≥13 mm and in other parts of the femur
≥30 mm, the ratio between width of the metastasis and bone ≥0.60,
and cortical destruction of the circumference ≥50% (Menck et al.,
1988). Another study examined retrospectively a total of 54 lesions
with 24 pathologic fractures. Out of 27 measurable lesions, there were
only 9 reported fractures. Still risk factors were deﬁned in maximal
Fig. 2. Number of studies published for each year since 1986 on fracture risk prediction in patients with femral metastatic lesion.
53E. Benca et al. / Bone Reports 5 (2016) 51–56axial cortical involvement to be ≥38 mm, width metastases to width of
the bone ratio ≥0.9 and maximal width of the lesion N30 mm (Dijkstra
et al., 1997). In the same study pain was not found to be a risk factor,
however the authors suggest to regard increasing local pain as an indi-
cation for a lesion with growing fracture risk (Dijkstra et al., 1997). A
prospective trial found only axial cortical involvement N30mm and cir-
cumferential cortical involvement N50% to be predictive parameter in
102 patients with 14 pathologic fractures (van der Linden et al., 2003).
In the retrospective study from1981 metastaseswere approximate-
ly drawn based on a radiograph on a rolled paper tube, representing the
affected bone. The paper was then unrolled and the size of themetasta-
sis was measured in order to ﬁnd the critical size of affected cortex,
whichwill cause a fracture (Fidler, 1981). Onemust assume a highmea-
surement error rate in this presented assessment technique compared
to today's available digital imaging and image processing techniques.
Furthermore the authors did not distinguish between different extrem-
ities and bones. A high number of patients, whowere considered at risk
for a fracture, did not sustain a pathological fracture and would have
been overtreated, if surgically treated. Still this article has been cited
nearly two-hundred times providing a clinical decision aid in orthopae-
dic oncology. Such and similar guidelines, based on plain radiographs
are used by most clinicians in fracture risk assessment. Radiological
evaluations using X-ray images are difﬁcult when standardized criteria
for patient positioning are not used. Van der Linden found that a differ-
ence of the largest axial cortical involvement for anterior–posterior (AP)
radiographs versus multidirectional radiographs was 1 mm (p= 0.15)
(van der Linden et al., 2003). Fracture prediction based on radiographs
is not possible in case of permeative or diffuse lesions without clear
boundaries. One study reported 12 out 96 (13%) metastases as perme-
ative (Menck et al., 1988), while Dijkstra et al. (1997)were not able to
perform an accurate measurement on 27 out of 54 patients (50%).
Keene et al. (1986) reported 296 out of 516 (57%)metastases as unmea-
surable due to unidentiﬁable margins on radiographs.
Also, subjective evaluations of plain radiographs should be per-
formedwith high cautiousness. In the absence of CT (computed tomog-
raphy) scans three different observers (a radiologist, an orthopaedic
surgeon and a radiation oncologist) estimated the percentage of circum-
ferential cortical involvement on plain radiographs using a two (≤50%,
N50%) and a three-tiered approach (≤33%, 33% b × ≤ 66%, N66%). The
separate scores of the observers were combined and in the case of
scoring discrepancies, the majority opinion was taken as to the ﬁnal
outcome. The ﬁner, three-tiered approach considered more lesions to
have a N50% cortical involvement irrespective of fracture (Van der
Linden et al., 2004), proving subjective assessments to be inaccurateand simply inadequate for fracture risk prediction in bones with meta-
static lesions.
Prediction of fracture risk based on radiographs and clinical datawas
the subject of most studies found on the given topic. Several authors
identiﬁed possible risk factors, which appears to be a mixed blessing.
While predictive values such as a speciﬁc cortical involvement have a
high negative predictive value (NPV), their positive predictive value
(PPV) is very low (Van der Linden et al., 2004), suggesting many, up
to two thirds of the patients without an impending fracture for preven-
tive surgery (Keene et al., 1986) (Table 2).
3.2. Clinical scoring systems
Dr. HiltonMirels, a South-African orthopaedic surgeon introduced in
1989 a weighted scoring system to quantify the risk of sustaining a
pathologic fracture in long bones with a metastatic lesion (Mirels,
1989). Mirels included 78 patients in the study and found a high inci-
dence of fractures in patients with pain aggravated by function, patients
with metastases occupying more than two-thirds of the bone diameter
and patients with lytic lesions compared to the ones with blastic lesions
(Mirels, 1989). The Mirels' score combined four radiographic and clini-
cal risk factors: degree of pain, lesional size or its cortical involvement,
lytic versus blastic nature, and anatomic location. Each of the four vari-
ables is given a score between 1 and 3 depending on the characteristics
found and a total score is derived by summing the individual scores.
Therefore, scores range from 4 to 12 points (Table 2), whereas a total
score of 7 or lower indicates a low chance of fracture; a total score of 8
is regarded as a borderline case, suggestive of an impending fracture
and the total score of 9 or higher indicates a high chance of fracture
and a necessity for prophylactic stabilisation (Mirels, 1989; Damron
et al., 2003).
The Mirels' score was found insufﬁciently speciﬁc to predict patho-
logic fractures in 102 patients with femoral metastases, of whom only
13% of lesions without fracture were low-risk (Van der Linden et al.,
2004). The positive predictive value was 14% in the same study under-
lying the weakness on fracture risk prediction based purely on clinical
data (Van der Linden et al., 2004).
3.3. Experimental biomechanical studies
The use of bone mineral content (BMC) and bone mineral density
(BMD) from DXA (dual energy X-ray absorptiometry) scans for predic-
tion of pathologic fractures was examined in a biomechanical ex-vivo
study (Michaeli et al., 1999). Thirty-two fresh-frozen human femora
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54 E. Benca et al. / Bone Reports 5 (2016) 51–56were loaded simulating two different loading scenarios: stair ascent and
external rotation with simulated circular 5 mm lytic defects between
the lesser trochanter and the neck of the femur. The setup allowed hor-
izontalmovement of the specimens using bearings in order to eliminate
uncontrolled forces and torques, while the load was applied vertically
on the specimens. The authors could determine a linear correlation be-
tween BMC and BMD of the total proximal femur and resultant failure
load for the stair ascent and external rotation conﬁguration (r2 = 0.78
and r2 = 0.69). However the BMC was reduced by simulated defects
by b1% in over a third of all specimens of proximal femora. The size
and geometry of defects varied from specimen to specimen, not speci-
ﬁed by the authors. Also no intact femora were included in the study
as a healthy control group. Nevertheless the authors suggest investigat-
ing different loading scenarios for different daily activities to estimate
the risk of fracture (Michaeli et al., 1999).
Sivasundaram et al. (2013) used synthetic femora to evaluate differ-
ent tumour defect locations on the proximal femur and found themedi-
al location to have a statistically lower stiffness values compared with
intact femora and have lower strength than femora with anterior and
posterior defects in axial load scenarios. In another studywith synthetic
bones therewas a high correlation between the defect size and torsional
stiffness (Amanatullah et al., 2014). However synthetic bones have a
different failure behaviour from real bone and should be used only to
enhance biomechanical test set-up accuracy or to study elastic proper-
ties (Hausmann, 2006).
In order to simulate lytic defects in trabecular bone, Hong and
colleagues harvested cylindrical cores of trabecular bone from the verte-
bral bodies of whale spines, created symmetric through-hole defect
groups with circular-hole diameter to specimen diameter ratios of
28%, 47% and 56% and subjected the specimen to uniaxial tension,
four-point bending or torsion until failure (Hong et al., 2004). They
found the load bearing capacities of the trabecular bone to be directly
proportional to the axial, bending, or torsional rigidity at the weakest
cross-section through the core containing the defect and concluded
that QCT (quantitative computed tomography), DXA andMRI (magnetic
resonance imaging) images of bones containing lytic defects can be used
to determine the structural rigidity of the cross-sectional geometric data
and predict the load bearing capacity of the involved bone (Hong et al.,
2004). The results point out the importance of accuracy in lesion geom-
etry for fracture prediction.
Lee hypothesized that fracture loads can be predicted using engi-
neering beam structural analysis combined with QCT data. Lee used
20 fresh-frozen femora with oval-shaped lytic defects in the cortex
(20%, 35% and 50% of the cortex) between lesser trochanter and the
neck of the femur. The results for ultimate load were validated with
ex-vivo tests and correlation values r2 b 0.87 were found for different
defect locations (Lee, 2007).
Data from biomechanical experiments show that guidelines, such as
Mirels' score or speciﬁc critical geometry seem to oversimplify the prob-
lem. The strength of the bone depends on one hand on size and shape of
the bone and its three-dimensional variation in density of the trabecular
and cortical bone (Michaeli et al., 1999), its microarchitecture and on
the other hand on size (Amanatullah et al., 2014) and shape (Kaneko
et al., 2003), but also the type of the lesion (Mirels, 1989; Keene et al.,Table 2
Mirels' scoring system (Mirels, 1989). It is based on four characteristics: site of lesion,
pain, nature of lesion and size of lesion. All the features were assigned progressive scores
ranging from 1 to 3.
Score
Variable 1 2 3
Site Upper limb Lower limb Peritrochanter
Pain Mild Moderate Functional
Lesion Blastic Mixed Lytic
Size b1/3 1/3–2/3 N2/3
55E. Benca et al. / Bone Reports 5 (2016) 51–561986). The bearing demands of the bone (with lesion) depend on
patient's size, weight, activity level (Mirels, 1989; Hipp et al., 1995;
Bergmann et al., 1993) and loading regimen (Michaeli et al., 1999;
Bergmann et al., 1993; Bergmann et al., 1989). Using engineering
methods it was not possible to ﬁnd any correlation between failure
load and following single image parameters: cross-sectional bone
density, axial and bending rigidity (both functions of bone geometry
and density), defect size or geometry (Lee, 2007). On the other hand a
correlation was found between failure loads from in-vitro tests and nu-
merical calculations, which include geometric and data on mechanical
properties.
A study group from the University of California (Kaneko et al.) could
even show, in a carefully conducted study, that cortical bone harvested
from patients with cancer generally can have degraded mechanical
properties, the elasticmodulus and compressive strength in comparison
from specimens from donorwithout cancer (Kaneko et al., 2003). Other
authors suspect different remodelling processes in metastatic bones
(e.g. after radiation therapy) and therefore different behaviours in
fatigue tests (Keyak et al., 2007). Other factors, which are likely to
weaken the bone, could be besides radiation also chemotherapy, immo-
bilisation, weight loss, sarcopenia and other (cancer-) related factors.
Provided data suggest that the speciﬁcation of one or only few
(geometrical) parameters cannot be regarded as a sufﬁcient method
to predict subject-speciﬁc impending fracture and furthermore to
classify lesions as not critical, which seems to be a bigger issue. Based
on reviewed literature, any method for predicting pathologic fracture
risk must include geometric data of the lesion and the host bone and
an adequate assessment of their material properties. The ultimate
choice of radiological method in patients with bone metastases is
governed by several parameters, such as accuracy, cost, radiation
exposure, accessibility and availability. Routine use of QCT, as the only
method able to discriminate changes in both the cortical and trabecular
bone (Hong et al., 2004), to study the three-dimensional geometry of
the bone and lesion would be most optimal.
High accuracy in pathologic fracture prediction was achieved using
QCT data in a simple numerical method, such as the beam theory (Lee,
2007) or computed tomography rigidity analysis (Anez-Bustillos et al.,
2014). Despite the relative simplicity and promising results, one must
consider more complex models with more than just a compressive
force to simulate physiological loading scenarios in the future studies.
3.4. Finite element analysis
The ﬁnite element method (FE) is a computer simulation method
which has been recognised as a powerful tool for prediction of bone
fragility especially structural stiffness, ultimate failure load, and local
mechanical stresses (Pahr et al., 2012; Varga et al., 2011; Zysset et al.,
2013; Dall'Ara et al., 2013; Keyak, 2001). FE models are based on CT
scans, from which bone geometry and quality, is retrieved based on
distribution of bone mineral density. Various loading patterns can
be simulated by applying speciﬁc boundary conditions and externalTable 3
Summary of FEA studies on stability of femora with simulated metastatic lesions. r… Pearson
validation.
Study Defect Source
data
FEA Type Number of
specimen
Healthy cont
group
Cheal et al. (1993) Simulated N/A Linear 1 No
Keyak et al. (2005) Simulated QCT Linear 12 No
Spruijt et al. (2006) Simulated QCT Linear 11 pairs No
Keyak et al. (2007) Simulated QCT Linear 12 No
Tanck et al. (2009) Simulated QCT Non-linear 5 pairs Yes
Derikx et al. (2012) Simulated QCT Non-linear 10 pairs Yes
Alexander Iii et al. (2013) Simulated QCT Linear 8 pairs Yes
Anez-Bustillos et al. (2014) Simulated QCT Non-linear 10 pairs Yes
Yosibash et al. (2014) Real QCT Linear 7 pairs Noforces allowing a non-invasive prediction of resulting stresses and
displacements including bone failure. Compared to other techniques,
FE simulation models allow an image-based quantiﬁcation of mechani-
cal behaviour, are thus patient-friendly and relatively cost-effective,
however underlying data assessment requires exposure to radiation;
also patients have to be scanned with a calibration phantom lying
underneath them in order to establish the reference between the BMD
and mechanical properties for each element, which is crucial for accu-
rate simulation.
Full potential of thismethod has not been exploited yet in theﬁeld of
metastatic bone lesions.
The earliest application of ﬁnite element analysis for prediction of
the stability reduction was performed by (Cheal et al., 1993). The rather
primitive ﬁnite element model in terms of number of isoparametric
quadratic elements and nodes, was based on a single femur from a
donor, nearly twenty years younger than the mean age of femora used
in the in-vitro tests, but still underestimated the absolute fracture resis-
tance of the femora by a factor of approximately three.
Several authors proved later the ability of linear (Keyak et al., 2007;
Tanck et al., 2009; Keyak et al., 2005; Yosibash et al.) and non-linear
(Hipp et al., 1995; Tanck et al., 2009; Derikx et al., 2012; Anez-Bustillos
et al., 2014) FE models generated from clinical CT scans to predict path-
ological fracture with a high accuracy (Table 3), and superior accuracy
over predication by clinical experts (Hipp et al., 1995; Tanck et al.,
2009). However all data were based on a small number of anatomic
specimens, mostly with one specimen per different defect groups in an
easily reproducible loading scenario, which does not sufﬁciently reﬂect
the spectrum physiological load bearing. Only one study performed
tests on femora with real metastatic lesions (Yosibash et al.). Further-
more the lack of a healthy control group (contralateral femur) in some
of the studies doesn't allow a calculation of reduction in stress and the
actual risk of fracture (Keyak et al., 2007, 2005). Furthermore FE models
are based on QCT data, which induces much higher radiation dose
compared to 2D imaging, such as DXA. Also FE analysis needs to show
its predictive supremacy over current methodology in clinical routine
with non-idealized scanning and loading conditions. So far no prospec-
tive studies on use of FE analysis in prediction of fracture risk exist.
Furthermore FE analysis requires rather sophisticated software for
image processing and analysis and a certain technical background for
the operators. It was estimated that generation and calculation of a FE
simulation model take about 8 h for a single femur with a metastatic
lesion (Anez-Bustillos et al., 2014). A certain level of automatization
will be necessary in order to make this method time- and cost-effective
before it can serve as a clinically useful decision support system routine.
4. Conclusion
A deﬁnition of a risk factor may provide a more objective guideline
for determining an individualized treatment strategy for each patient
with a metastatic lesion. Still only few research groups have dealt with
this question, which is reﬂected in the very low number of publications.product-moment correlation coefﬁcient between data sets from FEA and biomechanical
rol Number of different
defects
Biomechanical
validation
r2 Remarks
17 No – Poor performance of the FEA
12 Yes 0.84–0.96 Four-point bending test
1 Yes 0.68–0.72 Torsional loading
12 Yes N/A
5 Yes 0.92
10 Yes 0.90–0.93
1 Yes N/A
10 Yes 0.89
12 Yes 0.78
56 E. Benca et al. / Bone Reports 5 (2016) 51–56Several published approaches were not able to prove sufﬁcient validity
in prospective or retrospective studies based on purely clinical and
radiological data. Importantly, this review points out the lack of a gold
standard method. Mirels' scoring system is accurate in prediction of
impending fractures, but often fails to recognise non-impending
fractures and spares patients from overtreatment. While fracture risk
prediction based on pure clinical data shows poor results, engineering
methods provide high accuracy, but in idealized biomechanical setups,
which are difﬁcult to adapt to the variable physiological and pathophys-
iological conditions found in clinical routine. A combination of accurate
clinical assessment and biomechanical modelling could lead to
improved fracture risk prediction tools for decision support in clinical
environment. It will be essential to include exact anatomy, tissue
density and individual biomechanical load conditions to come to valid
individual prediction statements.
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